InvestorsHub Logo
Followers 23
Posts 1374
Boards Moderated 0
Alias Born 11/17/2006

Re: None

Wednesday, 04/27/2016 4:44:27 PM

Wednesday, April 27, 2016 4:44:27 PM

Post# of 2341355
$TPIV - partnership news with AZN - READY TO BREAK OUT SOON

TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute

http://finance.yahoo.com/news/tapimmune-announces-phase-2-ovarian-131500507.html

GOING HIGHER

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.